Pfizer Shares (Diluted) increased by 0.1% to 5.7B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.2%, from 5.7B to 5.7B. Over 2 years (FY 2021 to FY 2023), Shares (Diluted) shows relatively stable performance with a 0.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to basic shares indicates a higher reliance on equity-based compensation or convertible debt financing.
Weighted-average shares outstanding (diluted) includes the total number of basic common shares plus all additional share...
Commonly compared against basic shares to determine the 'dilution overhang' present in a company's capital structure.
is_weighted_shares_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 80M | 116M | 5.4B | 141M | 119M | 111M | 5.4B | 93M | 67M | 5.6B | 0 | 40M | 5.7B | 5.7B | 5.7B | 5.7B | 5.7B |
| QoQ Change | — | +45.0% | >999% | -97.4% | -15.6% | -6.7% | >999% | -98.3% | -28.0% | >999% | -100.0% | — | >999% | +0.2% | +0.1% | -0.1% | +0.1% |
| YoY Change | — | — | — | — | +48.8% | -4.3% | -1.3% | -34.0% | -43.7% | >999% | -100.0% | -57.0% | >999% | +1.0% | >999% | +0.2% | +0.2% |